• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors
Ann Rheum Dis. Mar 2005; 64(3): 444–448.
Published online Jul 29, 2004. doi:  10.1136/ard.2004.024943
PMCID: PMC1755385

Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus

Abstract

Objective: To investigate antibodies to complement 1q (anti-C1q) and investigate the correlation between anti-C1q titres and renal disease in systemic lupus erythematosus (SLE).

Methods: 151 SLE patients were studied. In patients with biopsy proven lupus nephritis (n = 77), activity of renal disease was categorised according to the BILAG renal score. Sera were tested for anti-C1q by enzyme immunoassay. Serum samples were randomly selected from 83 SLE patients who had no history of renal disease, and the positive and negative predictive value of the antibodies was studied.

Results: Patients with active lupus nephritis (BILAG A or B) had a higher prevalence of anti-C1q than those with no renal disease (74% v 32%; relative risk (RR) = 2.3 (95% confidence interval, 1.6 to 3.3)) (p<0.0001). There was no significant difference in anti-C1q prevalence between SLE without nephritis and SLE with non-active nephritis (BILAG C or D) (32% v 53%, p = 0.06) or between active and non-active nephritis (74% v 53%, p = 0.06). Patients with nephritis had higher anti-C1q levels than those without nephritis (36.0 U/ml (range 4.9 to 401.0) v 7.3 U/ml (4.9 to 401.0)) (p<0.001). Anti-C1q were found in 33 of 83 patients (39%) without history of renal disease. Nine of the 33 patients with anti-C1q developed lupus nephritis. The median renal disease-free interval was nine months. One patient with positive anti-C1q was diagnosed as having hypocomplementaemic urticarial vasculitis syndrome during follow up.

Conclusions: Anti-C1q in SLE are associated with renal involvement. Monitoring anti-C1q and their titres in SLE patients could be important for predicting renal flares.

Full Text

The Full Text of this article is available as a PDF (80K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 1996 Jun;39(6):894–903. [PubMed]
  • Berden JH. Lupus nephritis. Kidney Int. 1997 Aug;52(2):538–558. [PubMed]
  • Hahn BH. Antibodies to DNA. N Engl J Med. 1998 May 7;338(19):1359–1368. [PubMed]
  • Isenberg DA, Ravirajan CT, Rahman A, Kalsi J. The role of antibodies to DNA in systemic lupus erythematosus--a review and introduction to an international workshop on DNA antibodies held in London, May 1996. Lupus. 1997;6(3):290–304. [PubMed]
  • Lloyd W, Schur PH. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) 1981 May;60(3):208–217. [PubMed]
  • Swaak AJ, Aarden LA, Statius van Eps LW, Feltkamp TE. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum. 1979 Mar;22(3):226–235. [PubMed]
  • Bruns A, Bläss S, Hausdorf G, Burmester GR, Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 2000 Oct;43(10):2307–2315. [PubMed]
  • Amoura Z, Koutouzov S, Piette JC. The role of nucleosomes in lupus. Curr Opin Rheumatol. 2000 Sep;12(5):369–373. [PubMed]
  • Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum. 2000 Jan;43(1):76–84. [PubMed]
  • Walport MJ. Complement. First of two parts. N Engl J Med. 2001 Apr 5;344(14):1058–1066. [PubMed]
  • Walport MJ. Complement. Second of two parts. N Engl J Med. 2001 Apr 12;344(15):1140–1144. [PubMed]
  • Bowness P, Davies KA, Norsworthy PJ, Athanassiou P, Taylor-Wiedeman J, Borysiewicz LK, Meyer PA, Walport MJ. Hereditary C1q deficiency and systemic lupus erythematosus. QJM. 1994 Aug;87(8):455–464. [PubMed]
  • Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, Suzuki K. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol. 1984 Jan;30(1):104–116. [PubMed]
  • Wener MH, Uwatoko S, Mannik M. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum. 1989 May;32(5):544–551. [PubMed]
  • Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol. 1991 Feb;18(2):230–234. [PubMed]
  • Siegert CE, Daha MR, Halma C, van der Voort EA, Breedveld FC. IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin Exp Rheumatol. 1992 Jan-Feb;10(1):19–23. [PubMed]
  • Wisnieski JJ, Jones SM. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases. J Rheumatol. 1992 Jun;19(6):884–888. [PubMed]
  • Gunnarsson I, Rönnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I, Klareskog L. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumatol. 1997 Jan;36(1):32–37. [PubMed]
  • Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis. 1993 Dec;52(12):851–856. [PMC free article] [PubMed]
  • Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum. 1999 Jan;42(1):187–188. [PubMed]
  • Frémeaux-Bacchi Véronique, Noël Laure Hélène, Schifferli Jürg A. No lupus nephritis in the absence of antiC1q autoantibodies? Nephrol Dial Transplant. 2002 Dec;17(12):2041–2043. [PubMed]
  • Siegert CE, Kazatchkine MD, Sjöholm A, Würzner R, Loos M, Daha MR. Autoantibodies against C1q: view on clinical relevance and pathogenic role. Clin Exp Immunol. 1999 Apr;116(1):4–8. [PMC free article] [PubMed]
  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. [PubMed]
  • Austin HA, 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984 Apr;25(4):689–695. [PubMed]
  • Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DP, Viner N, Zoma A. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med. 1993 Jul;86(7):447–458. [PubMed]
  • Coremans IE, Daha MR, van der Voort EA, Muizert Y, Halma C, Breedveld FC. Antibodies against C1q in anti-glomerular basement membrane nephritis. Clin Exp Immunol. 1992 Feb;87(2):256–260. [PMC free article] [PubMed]
  • Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999 Jul;42(7):1309–1311. [PubMed]
  • Horváth L, Czirják L, Fekete B, Jakab L, Pozsonyi T, Kalabay L, Romics L, Miklós K, Varga L, Prohászka Z, et al. High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol. 2001 Nov-Dec;19(6):667–672. [PubMed]
  • Haseley LA, Wisnieski JJ, Denburg MR, Michael-Grossman AR, Ginzler EM, Gourley MF, Hoffman JH, Kimberly RP, Salmon JE. Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc gamma RIIA alleles. Kidney Int. 1997 Nov;52(5):1375–1380. [PubMed]
  • Coremans IE, Spronk PE, Bootsma H, Daha MR, van der Voort EA, Kater L, Breedveld FC, Kallenberg CG. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis. 1995 Oct;26(4):595–601. [PubMed]
  • Moroni G, Trendelenburg M, Del Papa N, Quaglini S, Raschi E, Panzeri P, Testoni C, Tincani A, Banfi G, Balestrieri G, et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis. 2001 Mar;37(3):490–498. [PubMed]
  • Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol. 2000 Jun;53(6):424–432. [PMC free article] [PubMed]
  • Rönnelid J, Huang YH, Norrlander T, Rogberg S, Nilsson B, Gustafsson R, Klareskog L. Short-term kinetics of the humoral anti-C1q response in SLE using the ELISPOT method: fast decline in production in response to steroids. Scand J Immunol. 1994 Aug;40(2):243–250. [PubMed]
  • Gunnarsson Iva, Sundelin Birgitta, Heimbürger Mikael, Forslid Jan, van Vollenhoven Ronald, Lundberg Ingrid, Jacobson Stefan H. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria. J Rheumatol. 2002 Apr;29(4):693–699. [PubMed]
  • Pickering MC, Walport MJ. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 2000 Feb;39(2):133–141. [PubMed]
  • Frémeaux-Bacchi V, Weiss L, Demouchy C, Blouin J, Kazatchkine MD. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus. 1996 Jun;5(3):216–220. [PubMed]
  • Jonsson H, Sturfelt G, Mårtensson U, Truedsson L, Sjöholm AG. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1995 Sep-Oct;13(5):573–580. [PubMed]
  • Swaak AJ, Groenwold J, Bronsveld W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis. 1986 May;45(5):359–366. [PMC free article] [PubMed]
  • Mannik M, Wener MH. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 1997 Aug;40(8):1504–1511. [PubMed]
  • Trouw LA, Seelen MA, Duijs JMGJ, Benediktsson H, Van Kooten C, Daha MR. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies. Clin Exp Immunol. 2003 Apr;132(1):32–39. [PMC free article] [PubMed]

Figures and Tables

Figure 1
 Anti-C1q antibody titres in 151 patients with systemic lupus erythematosus. Dashed lines indicate cut off for positivity. This graph shows the median, first to third quartiles (box), interquartile range (whiskers), and outliers (circles). Higher ...
Figure 2
 Anti-C1q titres and activity of renal disease in 77 patients with systemic lupus erythematosus and renal involvement. This graph shows the median, first and third quartiles (box), interquartile range (whiskers), and outliers (circles). Higher ...

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...